Know Labs (NYSEAMERICAN:KNW) Trading 3.8% Higher – Should You Buy?

Know Labs, Inc. (NYSEAMERICAN:KNW) shares traded up 3.8% during mid-day trading on Monday . The company traded as high as $2.17 and last traded at $2.1390. Approximately 612,050 shares traded hands during trading, a decline of 86% from the average daily volume of 4,376,964 shares. The stock had previously closed at $2.06.

Know Labs Price Performance

The stock has a market capitalization of $16.04 million, a P/E ratio of -0.33 and a beta of 1.83. The stock’s fifty day moving average price is $2.14 and its 200 day moving average price is $2.14.

Hedge Funds Weigh In On Know Labs

An institutional investor recently bought a new position in Know Labs stock. Corient Private Wealth LLC bought a new position in Know Labs, Inc. (NYSEAMERICAN:KNW) in the second quarter, according to its most recent filing with the SEC. The firm bought 50,000 shares of the company’s stock, valued at approximately $99,000. Corient Private Wealth LLC owned approximately 0.67% of Know Labs as of its most recent SEC filing. 23.96% of the stock is currently owned by hedge funds and other institutional investors.

About Know Labs

Know Labs, Inc (NYSE American: KNW) is a life sciences company developing non‐invasive sensing solutions based on its proprietary Bio‐RFID platform. The technology employs low‐power radio‐frequency spectroscopy to scan the skin, enabling the detection of biochemical markers such as blood glucose, hydration levels and alcohol concentration without the need for blood draws or fingersticks. By applying sophisticated signal‐processing algorithms to reflected electromagnetic waves, the company aims to deliver real‐time, continuous monitoring devices that could transform standard practices in healthcare and wellness.

The company is focused on advancing its flagship prototype devices through clinical validation studies and regulatory pathways.